A detailed history of Thompson Investment Management, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 2,462 shares of MNKD stock, worth $12,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,462
Previous 2,462 -0.0%
Holding current value
$12,383
Previous $8,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 24, 2023

BUY
$3.95 - $5.63 $9,724 - $13,861
2,462 New
2,462 $10,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.29B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Thompson Investment Management, Inc. Portfolio

Follow Thompson Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Investment Management, Inc. with notifications on news.